Tahari, Albaser M.

HRN: 22-71-58  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/11/2025
10/17/2025
IV
350mg
Q6
PCAP C
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: